Intravenous Fosfomycin for Systemic Multidrug-Resistant Infections
August 20th 2020Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.
Read More